Literature DB >> 16476990

Role of non-raft cholesterol in lymphocytic choriomeningitis virus infection via alpha-dystroglycan.

Waris A Shah1, Huashan Peng1, Salvatore Carbonetto1.   

Abstract

Dystroglycan (DG) is an extracellular matrix receptor necessary for the development of metazoans from flies to humans and is also an entry route for various pathogens. Lymphocytic choriomeningitis virus (LCMV), a member of the family Arenaviridae, infects by binding to alpha-DG. Here, the role of cholesterol lipid rafts in infection by LCMV via alpha-DG was investigated. The cholesterol-sequestering drugs methyl-beta-cyclodextrin (MbetaCD), filipin and nystatin inhibited the infectivity of LCMV selectively, but did not affect infection by vesicular stomatitis virus. Cholesterol loading after depletion with MbetaCD restored infectivity to control levels. DG was not found in lipid rafts identified with the raft marker ganglioside GM1. Treatment with MbetaCD, however, enhanced the solubility of DG. This may reflect the association of DG with cholesterol outside lipid rafts and suggests that association of DG with non-raft cholesterol is critical for infection by LCMV through alpha-DG.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476990     DOI: 10.1099/vir.0.81444-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Membrane cholesterol modulates {beta}-amyloid-dependent tau cleavage by inducing changes in the membrane content and localization of N-methyl-D-aspartic acid receptors.

Authors:  Alexandra M Nicholson; D Nicole Riherd Methner; Adriana Ferreira
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

2.  Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication.

Authors:  Katrin Schlie; Anna Maisa; Frank Lennartz; Ute Ströher; Wolfgang Garten; Thomas Strecker
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

3.  Sodium hydrogen exchangers contribute to arenavirus cell entry.

Authors:  Masaharu Iwasaki; Nhi Ngo; Juan C de la Torre
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

4.  Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.

Authors:  Masaharu Iwasaki; Shuzo Urata; Yoshitake Cho; Nhi Ngo; Juan C de la Torre
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

Review 5.  Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.

Authors:  Juan C Zapata; C David Pauza; Mahmoud M Djavani; Juan D Rodas; Dmitry Moshkoff; Joseph Bryant; Eugene Ateh; Cybele Garcia; Igor S Lukashevich; Maria S Salvato
Journal:  Antiviral Res       Date:  2011-07-27       Impact factor: 5.970

6.  Neuroinvasion and cognitive impairment in comorbid alcohol dependence and chronic viral infection: An initial investigation.

Authors:  Jennifer M Loftis; Jonathan Taylor; Rebekah Hudson; Evan J Firsick
Journal:  J Neuroimmunol       Date:  2019-07-10       Impact factor: 3.478

7.  Canine distemper virus infection requires cholesterol in the viral envelope.

Authors:  Heidi Imhoff; Veronika von Messling; Georg Herrler; Ludwig Haas
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

8.  Assembly of arenavirus envelope glycoprotein GPC in detergent-soluble membrane microdomains.

Authors:  Sudhakar S Agnihothram; Brooke Dancho; Kenneth W Grant; Mark L Grimes; Douglas S Lyles; Jack H Nunberg
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

9.  Interdependence of laminin-mediated clustering of lipid rafts and the dystrophin complex in astrocytes.

Authors:  Geoffroy Noël; Daniel Kai Long Tham; Hakima Moukhles
Journal:  J Biol Chem       Date:  2009-05-18       Impact factor: 5.157

10.  Borna disease virus requires cholesterol in both cellular membrane and viral envelope for efficient cell entry.

Authors:  Roberto Clemente; Aymeric de Parseval; Mar Perez; Juan C de la Torre
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.